Burzynski Research Institute Inc (BZYR)
OTHER OTC:BZYR
US Market

Burzynski Research Institute (BZYR) Stock Price & Analysis

6 Followers

BZYR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.01 - $0.09
Previous Close$0.04
Volume19.75K
Average Volume (3M)9.03K
Market Cap
$5.52M
Enterprise Value$5.52M
Total Cash (Recent Filing)$297.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)
Beta-0.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding131,448,444
10 Day Avg. Volume172
30 Day Avg. Volume9,030
Standard Deviation0.70
R-Squared0.01
Alpha0.12
Financial Highlights & Ratios
Price to Book (P/B)-158.54
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-7.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-4.33
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

0.00%0.00%0.02%99.98%
0.00%
Insiders
0.00%
Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

BZYR FAQ

What was Burzynski Research Institute Inc’s price range in the past 12 months?
Burzynski Research Institute Inc lowest stock price was $0.01 and its highest was $0.09 in the past 12 months.
    What is Burzynski Research Institute Inc’s market cap?
    Currently, no data Available
    When is Burzynski Research Institute Inc’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Burzynski Research Institute Inc’s earnings last quarter?
    Currently, no data Available
    Is Burzynski Research Institute Inc overvalued?
    According to Wall Street analysts Burzynski Research Institute Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Burzynski Research Institute Inc pay dividends?
      Burzynski Research Institute Inc does not currently pay dividends.
      What is Burzynski Research Institute Inc’s EPS estimate?
      Burzynski Research Institute Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Burzynski Research Institute Inc have?
      Burzynski Research Institute Inc has 131,448,440 shares outstanding.
        What happened to Burzynski Research Institute Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Burzynski Research Institute Inc?
        Currently, no hedge funds are holding shares in BZYR
        ---

        Burzynski Research Institute Stock Smart Score

        10
        Unlock Smart Score
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Technicals

        SMA
        Positive
        20 days / 200 days
        Momentum
        -55.29%
        12-Months-Change

        Fundamentals

        Return on Equity
        Trailing 12-Months
        Asset Growth
        17.57%
        Trailing 12-Months

        Company Description

        Burzynski Research Institute Inc

        Burzynski Research Institute, Inc. engages in research, production, marketing, promotion and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids under the trade name Antineoplastons. The company was founded by Stanislaw R. Burzynski in 1984 and is headquartered in Houston, TX.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Novavax
        Dynavax
        Gilead Sciences
        Kala Pharmaceuticals
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis